Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Safety & Regulatory Compliance
  • Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

Impacting People's Lives

"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.

LEARN MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.

COMPLIANCE OVERVIEW
Safety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Global Trends in R&D 2024

READ MORE

EMEA Insights

"IQVIA thought leadership with a focus on EMEA.

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • IQVIA Connected Intelligence™
  • IQVIA Healthcare-grade AI™
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Patient Experience powered by Apple
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
IQVIA AI is Healthcare-grade AI

Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.

LEARN MORE
Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
IQVIA Patient Experience Solutions powered by Apple

Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm. IQVIA and Apple are collaborating to bring this exciting future of personalized care directly to devices patients already have and use.

LEARN MORE
MAIN/Careers
Careers/
WORKING AT IQVIA

Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.

LEARN MORE
LIFE AT IQVIA

Careers, culture and everything in between. Find out what’s going on right here, right now.

LEARN MORE

WE’RE HIRING

"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

SEARCH JOBS
MAIN/Contact Us
Contact Us/
Scientific Poster
IQVIA publications in ASCO21 virtual science program
May 27, 2021

The American Society of Clinical Oncology 2021 Annual Meeting features 21 abstracts from IQVIA demonstrating Connected Intelligence solutions spanning precision medicine, immuno-oncology trials, and real world insights during a global pandemic.

You may also be interested in

White Paper
Transcending the Traditional Focus of Oncology Commercialisation
Scientific Poster
Impact of tumour genomic characteristics on healthcare resource utilisation and real-world outcomes in patients with non-small cell lung cancer
Podcast
How AI and Real World Data are Reshaping Medical Affairs
Podcast
Beyond Static Reports – Dynamic Dashboards for Patient-Level Insights
Scientific Poster
What counts as a cancer diagnosis in real world data? Cohort identification and oncology endpoints in a linked genomic-clinical database
Podcast
The Pharmaceutical Commerce Podcast | RWD "Fitness" Steps for Pharma
Prev
Next
Contact Us

Featured Abstracts

Abstract
Evaluating real-world overall survival (rwOS) across oncology data sources: Friends of Cancer Research non-small cell lung cancer pilot study.

Publication-Only Abstracts: Health Services Research and Quality Improvement

Abstract
Advanced tumor progression detection by leveraging EHR based convolutional neural network boosting approaches.

Publication-Only Abstracts: Care Delivery and Regulatory Policy

Abstract
Why are oncologists not testing all NSCLC patients for biomarkers in the U.S. market?

Publication-Only Abstracts: Lung Cancer—Non-Small Cell Metastatic

See below for more ASCO21 abstracts from IQVIA authors.  

Breast cancer survivorship and level of institutional involvement utilizing integrative oncology.

Publication-Only Abstracts: Health Services Research and Quality Improvement

View Abstract

 

Awareness, perceptions, and usage of whole person integrative oncology practices: Similarities and differences between breast cancer patients and oncologists.

Publication-Only Abstracts: Symptoms and Survivorship

View Abstract

 

Results from VERONICA: A randomized, phase II study of second-/third-line venetoclax (VEN) + fulvestrant (F) versus F alone in estrogen receptor (ER)-positive, HER2-negative, locally advanced, or metastatic breast cancer (LA/MBC).

Oral Abstract Session: Breast Cancer—Metastatic

View Abstract

 

A phase 1 study of an off-the shelf, multi-neoantigen vector (ADXS-503) in subjects with metastatic non-small cell lung cancer (NSCLC) progressing on pembrolizumab as last therapy.

Poster Session: Developmental Therapeutics—Immunotherapy

View Abstract

 

An international, multicenter, real-world analysis of epithelial ovarian cancer treatment and outcomes.

Poster Session: Gynecologic Cancer

View Abstract

 

Obinutuzumab short-duration infusion (SDI) in previously untreated advanced follicular lymphoma: Results from the end of induction analysis of the phase IV GAZELLE study.

Poster Session: Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

View Abstract

 

Patient-reported symptoms, functioning, and quality of life (QoL) in patients treated with cemiplimab monotherapy for first-line treatment of advanced NSCLC with PD-L1 ≥50%: Results from EMPOWER-Lung 1 study.

Poster Session: Lung Cancer—Non-Small Cell Metastatic

View Abstract

 

Health-related quality of life (HRQoL) in patients (pts) with locally advanced basal cell carcinoma (laBCC) treated with cemiplimab: Analysis of a phase II, open-label clinical trial.

Poster Session: Melanoma/Skin Cancers

View Abstract

 

The impact of cancer-related diarrhea on changes in cancer therapy patterns.

Poster Session: Symptoms and Survivorship

View Abstract

 

Oncology clinical research landscape in Middle East and North Africa (MENA) region: Challenges and proposed solutions.

Publication-Only Abstracts: Care Delivery and Regulatory Policy

View Abstract

 

OEN: Multi-center, international, real-world evidence studies performed using health records without data pooling—The use of a common data model and shared analytical methods.

Publication-Only Abstracts: Care Delivery and Regulatory Policy

View Abstract

 

Phase I study of BJ-001, a tumor-targeting interleukin-15 fusion protein, in patients with solid tumor.

Publication-Only Abstracts: Developmental Therapeutics—Immunotherapy

View Abstract

 

Cost-effectiveness of atezolizumab monotherapy versus pembrolizumab monotherapy for first-line (1L) treatment of metastatic non-small cell lung cancer (mNSCLC).

Publication-Only Abstracts: Health Services Research and Quality Improvement

View Abstract

 

Characterizing unplanned resource utilization associated with cancer-related diarrhea.

Publication-Only Abstracts: Health Services Research and Quality Improvement

View Abstract

 

Healthcare utilization and costs associated with cancer-related diarrhea.

Publication-Only Abstracts: Health Services Research and Quality Improvement

View Abstract

 

Incidence of pneumonitis among limited-stage small cell lung cancer patients exposed to concurrent chemoradiation: A systematic literature review and meta-analysis.

Publication-Only Abstracts: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

View Abstract

 

Chemoradiation-induced pneumonitis in patients with unresectable stage III non-small cell lung cancer: A meta-analysis.

Publication-Only Abstracts: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

View Abstract

 

Psychometric properties of patient reported outcome (PRO) instruments in patients with small cell lung cancer (SCLC) in RESILIENT part 1.

Publication-Only Abstracts: Symptoms and Survivorship

View Abstract